Want to join the conversation?
On the acquisition pipeline, Brian Drab of William Blair, asks if the company is seeing opportunities in the fragmented filtration market. $DCI replied by saying that it continues to work its new and improved process for acquisitions. $DCI has a robust pipeline & continues to work that diligently. $DCI added that it will remain a disciplined buyer.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.